Global Giant Cell Arteritis Therapeutic Market Growth (Status and Outlook) 2026-2032
The global Giant Cell Arteritis Therapeutic market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Giant cell arteritis (GCA) is a granulomatous medium and large-vessel vasculitis. It is the most common form of systemic vasculitis, with an incidence of between 15 and 25 cases per 100,000 persons over 50 years of age.
United States market for Giant Cell Arteritis Therapeutic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Giant Cell Arteritis Therapeutic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Giant Cell Arteritis Therapeutic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Giant Cell Arteritis Therapeutic players cover Sanofi, Kiniksa Pharmaceuticals, Ltd., Regeneron, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Giant Cell Arteritis Therapeutic Industry Forecast? looks at past sales and reviews total world Giant Cell Arteritis Therapeutic sales in 2025, providing a comprehensive analysis by region and market sector of projected Giant Cell Arteritis Therapeutic sales for 2026 through 2032. With Giant Cell Arteritis Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Giant Cell Arteritis Therapeutic industry.
This Insight Report provides a comprehensive analysis of the global Giant Cell Arteritis Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Giant Cell Arteritis Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Giant Cell Arteritis Therapeutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Giant Cell Arteritis Therapeutic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Giant Cell Arteritis Therapeutic.
This report presents a comprehensive overview, market shares, and growth opportunities of Giant Cell Arteritis Therapeutic market by product type, application, key players and key regions and countries.
Segmentation by Type:
Giant cell arteritis (GCA) is a granulomatous medium and large-vessel vasculitis. It is the most common form of systemic vasculitis, with an incidence of between 15 and 25 cases per 100,000 persons over 50 years of age.
United States market for Giant Cell Arteritis Therapeutic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Giant Cell Arteritis Therapeutic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Giant Cell Arteritis Therapeutic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Giant Cell Arteritis Therapeutic players cover Sanofi, Kiniksa Pharmaceuticals, Ltd., Regeneron, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Giant Cell Arteritis Therapeutic Industry Forecast? looks at past sales and reviews total world Giant Cell Arteritis Therapeutic sales in 2025, providing a comprehensive analysis by region and market sector of projected Giant Cell Arteritis Therapeutic sales for 2026 through 2032. With Giant Cell Arteritis Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Giant Cell Arteritis Therapeutic industry.
This Insight Report provides a comprehensive analysis of the global Giant Cell Arteritis Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Giant Cell Arteritis Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Giant Cell Arteritis Therapeutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Giant Cell Arteritis Therapeutic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Giant Cell Arteritis Therapeutic.
This report presents a comprehensive overview, market shares, and growth opportunities of Giant Cell Arteritis Therapeutic market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Prednisone
- Methotrexate
- Tocilizumab
- Aspirin
- Corticosteroids
- Immunosuppressive Agents
- Anticoagulants
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Kiniksa Pharmaceuticals, Ltd.
- Regeneron
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- AbbVie, Inc.
- Bristol-Myers Squibb Company
- Abbott
- Johnson & Johnson Services, Inc.
- Johns Hopkins Hospital
- Fortis Healthcare
- American College of Rheumatology
- Duke University Health System
- Lahey Clinic Foundation
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Giant Cell Arteritis Therapeutic Market Size (2021-2032)
2.1.2 Giant Cell Arteritis Therapeutic Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Giant Cell Arteritis Therapeutic by Country/Region (2021, 2025 & 2032)
2.2 Giant Cell Arteritis Therapeutic Segment by Type
2.2.1 Prednisone
2.2.2 Methotrexate
2.2.3 Tocilizumab
2.2.4 Aspirin
2.2.5 Giant Cell Arteritis Therapeutic Market Size by Type
2.2.5.1 Giant Cell Arteritis Therapeutic Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2021-2026)
2.3 Giant Cell Arteritis Therapeutic Segment by Application
2.3.1 Corticosteroids
2.3.2 Immunosuppressive Agents
2.3.3 Anticoagulants
2.3.4 Others
2.3.5 Giant Cell Arteritis Therapeutic Market Size by Application
2.3.5.1 Giant Cell Arteritis Therapeutic Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Giant Cell Arteritis Therapeutic Market Size Market Share by Application (2021-2026)
3 GIANT CELL ARTERITIS THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Giant Cell Arteritis Therapeutic Market Size Market Share by Player
3.1.1 Global Giant Cell Arteritis Therapeutic Revenue by Player (2021-2026)
3.1.2 Global Giant Cell Arteritis Therapeutic Revenue Market Share by Player (2021-2026)
3.2 Global Giant Cell Arteritis Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GIANT CELL ARTERITIS THERAPEUTIC BY REGION
4.1 Giant Cell Arteritis Therapeutic Market Size by Region (2021-2026)
4.2 Global Giant Cell Arteritis Therapeutic Annual Revenue by Country/Region (2021-2026)
4.3 Americas Giant Cell Arteritis Therapeutic Market Size Growth (2021-2026)
4.4 APAC Giant Cell Arteritis Therapeutic Market Size Growth (2021-2026)
4.5 Europe Giant Cell Arteritis Therapeutic Market Size Growth (2021-2026)
4.6 Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026)
5.2 Americas Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026)
5.3 Americas Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Giant Cell Arteritis Therapeutic Market Size by Region (2021-2026)
6.2 APAC Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026)
6.3 APAC Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026)
7.2 Europe Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026)
7.3 Europe Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Giant Cell Arteritis Therapeutic by Region (2021-2026)
8.2 Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026)
8.3 Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GIANT CELL ARTERITIS THERAPEUTIC MARKET FORECAST
10.1 Global Giant Cell Arteritis Therapeutic Forecast by Region (2027-2032)
10.1.1 Global Giant Cell Arteritis Therapeutic Forecast by Region (2027-2032)
10.1.2 Americas Giant Cell Arteritis Therapeutic Forecast
10.1.3 APAC Giant Cell Arteritis Therapeutic Forecast
10.1.4 Europe Giant Cell Arteritis Therapeutic Forecast
10.1.5 Middle East & Africa Giant Cell Arteritis Therapeutic Forecast
10.2 Americas Giant Cell Arteritis Therapeutic Forecast by Country (2027-2032)
10.2.1 United States Market Giant Cell Arteritis Therapeutic Forecast
10.2.2 Canada Market Giant Cell Arteritis Therapeutic Forecast
10.2.3 Mexico Market Giant Cell Arteritis Therapeutic Forecast
10.2.4 Brazil Market Giant Cell Arteritis Therapeutic Forecast
10.3 APAC Giant Cell Arteritis Therapeutic Forecast by Region (2027-2032)
10.3.1 China Giant Cell Arteritis Therapeutic Market Forecast
10.3.2 Japan Market Giant Cell Arteritis Therapeutic Forecast
10.3.3 Korea Market Giant Cell Arteritis Therapeutic Forecast
10.3.4 Southeast Asia Market Giant Cell Arteritis Therapeutic Forecast
10.3.5 India Market Giant Cell Arteritis Therapeutic Forecast
10.3.6 Australia Market Giant Cell Arteritis Therapeutic Forecast
10.4 Europe Giant Cell Arteritis Therapeutic Forecast by Country (2027-2032)
10.4.1 Germany Market Giant Cell Arteritis Therapeutic Forecast
10.4.2 France Market Giant Cell Arteritis Therapeutic Forecast
10.4.3 UK Market Giant Cell Arteritis Therapeutic Forecast
10.4.4 Italy Market Giant Cell Arteritis Therapeutic Forecast
10.4.5 Russia Market Giant Cell Arteritis Therapeutic Forecast
10.5 Middle East & Africa Giant Cell Arteritis Therapeutic Forecast by Region (2027-2032)
10.5.1 Egypt Market Giant Cell Arteritis Therapeutic Forecast
10.5.2 South Africa Market Giant Cell Arteritis Therapeutic Forecast
10.5.3 Israel Market Giant Cell Arteritis Therapeutic Forecast
10.5.4 Turkey Market Giant Cell Arteritis Therapeutic Forecast
10.6 Global Giant Cell Arteritis Therapeutic Forecast by Type (2027-2032)
10.7 Global Giant Cell Arteritis Therapeutic Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Giant Cell Arteritis Therapeutic Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Giant Cell Arteritis Therapeutic Product Offered
11.1.3 Sanofi Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Kiniksa Pharmaceuticals, Ltd.
11.2.1 Kiniksa Pharmaceuticals, Ltd. Company Information
11.2.2 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Product Offered
11.2.3 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Kiniksa Pharmaceuticals, Ltd. Main Business Overview
11.2.5 Kiniksa Pharmaceuticals, Ltd. Latest Developments
11.3 Regeneron
11.3.1 Regeneron Company Information
11.3.2 Regeneron Giant Cell Arteritis Therapeutic Product Offered
11.3.3 Regeneron Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Regeneron Main Business Overview
11.3.5 Regeneron Latest Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Information
11.4.2 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product Offered
11.4.3 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 GlaxoSmithKline plc Main Business Overview
11.4.5 GlaxoSmithKline plc Latest Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Information
11.5.2 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product Offered
11.5.3 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.6 Novartis AG
11.6.1 Novartis AG Company Information
11.6.2 Novartis AG Giant Cell Arteritis Therapeutic Product Offered
11.6.3 Novartis AG Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Novartis AG Main Business Overview
11.6.5 Novartis AG Latest Developments
11.7 AbbVie, Inc.
11.7.1 AbbVie, Inc. Company Information
11.7.2 AbbVie, Inc. Giant Cell Arteritis Therapeutic Product Offered
11.7.3 AbbVie, Inc. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AbbVie, Inc. Main Business Overview
11.7.5 AbbVie, Inc. Latest Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Information
11.8.2 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product Offered
11.8.3 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Bristol-Myers Squibb Company Main Business Overview
11.8.5 Bristol-Myers Squibb Company Latest Developments
11.9 Abbott
11.9.1 Abbott Company Information
11.9.2 Abbott Giant Cell Arteritis Therapeutic Product Offered
11.9.3 Abbott Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Abbott Main Business Overview
11.9.5 Abbott Latest Developments
11.10 Johnson & Johnson Services, Inc.
11.10.1 Johnson & Johnson Services, Inc. Company Information
11.10.2 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Product Offered
11.10.3 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Johnson & Johnson Services, Inc. Main Business Overview
11.10.5 Johnson & Johnson Services, Inc. Latest Developments
11.11 Johns Hopkins Hospital
11.11.1 Johns Hopkins Hospital Company Information
11.11.2 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product Offered
11.11.3 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Johns Hopkins Hospital Main Business Overview
11.11.5 Johns Hopkins Hospital Latest Developments
11.12 Fortis Healthcare
11.12.1 Fortis Healthcare Company Information
11.12.2 Fortis Healthcare Giant Cell Arteritis Therapeutic Product Offered
11.12.3 Fortis Healthcare Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Fortis Healthcare Main Business Overview
11.12.5 Fortis Healthcare Latest Developments
11.13 American College of Rheumatology
11.13.1 American College of Rheumatology Company Information
11.13.2 American College of Rheumatology Giant Cell Arteritis Therapeutic Product Offered
11.13.3 American College of Rheumatology Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 American College of Rheumatology Main Business Overview
11.13.5 American College of Rheumatology Latest Developments
11.14 Duke University Health System
11.14.1 Duke University Health System Company Information
11.14.2 Duke University Health System Giant Cell Arteritis Therapeutic Product Offered
11.14.3 Duke University Health System Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Duke University Health System Main Business Overview
11.14.5 Duke University Health System Latest Developments
11.15 Lahey Clinic Foundation
11.15.1 Lahey Clinic Foundation Company Information
11.15.2 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product Offered
11.15.3 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Lahey Clinic Foundation Main Business Overview
11.15.5 Lahey Clinic Foundation Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Giant Cell Arteritis Therapeutic Market Size (2021-2032)
2.1.2 Giant Cell Arteritis Therapeutic Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Giant Cell Arteritis Therapeutic by Country/Region (2021, 2025 & 2032)
2.2 Giant Cell Arteritis Therapeutic Segment by Type
2.2.1 Prednisone
2.2.2 Methotrexate
2.2.3 Tocilizumab
2.2.4 Aspirin
2.2.5 Giant Cell Arteritis Therapeutic Market Size by Type
2.2.5.1 Giant Cell Arteritis Therapeutic Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2021-2026)
2.3 Giant Cell Arteritis Therapeutic Segment by Application
2.3.1 Corticosteroids
2.3.2 Immunosuppressive Agents
2.3.3 Anticoagulants
2.3.4 Others
2.3.5 Giant Cell Arteritis Therapeutic Market Size by Application
2.3.5.1 Giant Cell Arteritis Therapeutic Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Giant Cell Arteritis Therapeutic Market Size Market Share by Application (2021-2026)
3 GIANT CELL ARTERITIS THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Giant Cell Arteritis Therapeutic Market Size Market Share by Player
3.1.1 Global Giant Cell Arteritis Therapeutic Revenue by Player (2021-2026)
3.1.2 Global Giant Cell Arteritis Therapeutic Revenue Market Share by Player (2021-2026)
3.2 Global Giant Cell Arteritis Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GIANT CELL ARTERITIS THERAPEUTIC BY REGION
4.1 Giant Cell Arteritis Therapeutic Market Size by Region (2021-2026)
4.2 Global Giant Cell Arteritis Therapeutic Annual Revenue by Country/Region (2021-2026)
4.3 Americas Giant Cell Arteritis Therapeutic Market Size Growth (2021-2026)
4.4 APAC Giant Cell Arteritis Therapeutic Market Size Growth (2021-2026)
4.5 Europe Giant Cell Arteritis Therapeutic Market Size Growth (2021-2026)
4.6 Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026)
5.2 Americas Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026)
5.3 Americas Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Giant Cell Arteritis Therapeutic Market Size by Region (2021-2026)
6.2 APAC Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026)
6.3 APAC Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026)
7.2 Europe Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026)
7.3 Europe Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Giant Cell Arteritis Therapeutic by Region (2021-2026)
8.2 Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026)
8.3 Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GIANT CELL ARTERITIS THERAPEUTIC MARKET FORECAST
10.1 Global Giant Cell Arteritis Therapeutic Forecast by Region (2027-2032)
10.1.1 Global Giant Cell Arteritis Therapeutic Forecast by Region (2027-2032)
10.1.2 Americas Giant Cell Arteritis Therapeutic Forecast
10.1.3 APAC Giant Cell Arteritis Therapeutic Forecast
10.1.4 Europe Giant Cell Arteritis Therapeutic Forecast
10.1.5 Middle East & Africa Giant Cell Arteritis Therapeutic Forecast
10.2 Americas Giant Cell Arteritis Therapeutic Forecast by Country (2027-2032)
10.2.1 United States Market Giant Cell Arteritis Therapeutic Forecast
10.2.2 Canada Market Giant Cell Arteritis Therapeutic Forecast
10.2.3 Mexico Market Giant Cell Arteritis Therapeutic Forecast
10.2.4 Brazil Market Giant Cell Arteritis Therapeutic Forecast
10.3 APAC Giant Cell Arteritis Therapeutic Forecast by Region (2027-2032)
10.3.1 China Giant Cell Arteritis Therapeutic Market Forecast
10.3.2 Japan Market Giant Cell Arteritis Therapeutic Forecast
10.3.3 Korea Market Giant Cell Arteritis Therapeutic Forecast
10.3.4 Southeast Asia Market Giant Cell Arteritis Therapeutic Forecast
10.3.5 India Market Giant Cell Arteritis Therapeutic Forecast
10.3.6 Australia Market Giant Cell Arteritis Therapeutic Forecast
10.4 Europe Giant Cell Arteritis Therapeutic Forecast by Country (2027-2032)
10.4.1 Germany Market Giant Cell Arteritis Therapeutic Forecast
10.4.2 France Market Giant Cell Arteritis Therapeutic Forecast
10.4.3 UK Market Giant Cell Arteritis Therapeutic Forecast
10.4.4 Italy Market Giant Cell Arteritis Therapeutic Forecast
10.4.5 Russia Market Giant Cell Arteritis Therapeutic Forecast
10.5 Middle East & Africa Giant Cell Arteritis Therapeutic Forecast by Region (2027-2032)
10.5.1 Egypt Market Giant Cell Arteritis Therapeutic Forecast
10.5.2 South Africa Market Giant Cell Arteritis Therapeutic Forecast
10.5.3 Israel Market Giant Cell Arteritis Therapeutic Forecast
10.5.4 Turkey Market Giant Cell Arteritis Therapeutic Forecast
10.6 Global Giant Cell Arteritis Therapeutic Forecast by Type (2027-2032)
10.7 Global Giant Cell Arteritis Therapeutic Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Giant Cell Arteritis Therapeutic Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Giant Cell Arteritis Therapeutic Product Offered
11.1.3 Sanofi Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Kiniksa Pharmaceuticals, Ltd.
11.2.1 Kiniksa Pharmaceuticals, Ltd. Company Information
11.2.2 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Product Offered
11.2.3 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Kiniksa Pharmaceuticals, Ltd. Main Business Overview
11.2.5 Kiniksa Pharmaceuticals, Ltd. Latest Developments
11.3 Regeneron
11.3.1 Regeneron Company Information
11.3.2 Regeneron Giant Cell Arteritis Therapeutic Product Offered
11.3.3 Regeneron Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Regeneron Main Business Overview
11.3.5 Regeneron Latest Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Information
11.4.2 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product Offered
11.4.3 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 GlaxoSmithKline plc Main Business Overview
11.4.5 GlaxoSmithKline plc Latest Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Information
11.5.2 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product Offered
11.5.3 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.6 Novartis AG
11.6.1 Novartis AG Company Information
11.6.2 Novartis AG Giant Cell Arteritis Therapeutic Product Offered
11.6.3 Novartis AG Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Novartis AG Main Business Overview
11.6.5 Novartis AG Latest Developments
11.7 AbbVie, Inc.
11.7.1 AbbVie, Inc. Company Information
11.7.2 AbbVie, Inc. Giant Cell Arteritis Therapeutic Product Offered
11.7.3 AbbVie, Inc. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AbbVie, Inc. Main Business Overview
11.7.5 AbbVie, Inc. Latest Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Information
11.8.2 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product Offered
11.8.3 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Bristol-Myers Squibb Company Main Business Overview
11.8.5 Bristol-Myers Squibb Company Latest Developments
11.9 Abbott
11.9.1 Abbott Company Information
11.9.2 Abbott Giant Cell Arteritis Therapeutic Product Offered
11.9.3 Abbott Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Abbott Main Business Overview
11.9.5 Abbott Latest Developments
11.10 Johnson & Johnson Services, Inc.
11.10.1 Johnson & Johnson Services, Inc. Company Information
11.10.2 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Product Offered
11.10.3 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Johnson & Johnson Services, Inc. Main Business Overview
11.10.5 Johnson & Johnson Services, Inc. Latest Developments
11.11 Johns Hopkins Hospital
11.11.1 Johns Hopkins Hospital Company Information
11.11.2 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product Offered
11.11.3 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Johns Hopkins Hospital Main Business Overview
11.11.5 Johns Hopkins Hospital Latest Developments
11.12 Fortis Healthcare
11.12.1 Fortis Healthcare Company Information
11.12.2 Fortis Healthcare Giant Cell Arteritis Therapeutic Product Offered
11.12.3 Fortis Healthcare Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Fortis Healthcare Main Business Overview
11.12.5 Fortis Healthcare Latest Developments
11.13 American College of Rheumatology
11.13.1 American College of Rheumatology Company Information
11.13.2 American College of Rheumatology Giant Cell Arteritis Therapeutic Product Offered
11.13.3 American College of Rheumatology Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 American College of Rheumatology Main Business Overview
11.13.5 American College of Rheumatology Latest Developments
11.14 Duke University Health System
11.14.1 Duke University Health System Company Information
11.14.2 Duke University Health System Giant Cell Arteritis Therapeutic Product Offered
11.14.3 Duke University Health System Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Duke University Health System Main Business Overview
11.14.5 Duke University Health System Latest Developments
11.15 Lahey Clinic Foundation
11.15.1 Lahey Clinic Foundation Company Information
11.15.2 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product Offered
11.15.3 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Lahey Clinic Foundation Main Business Overview
11.15.5 Lahey Clinic Foundation Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Giant Cell Arteritis Therapeutic Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Giant Cell Arteritis Therapeutic Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Prednisone
Table 4. Major Players of Methotrexate
Table 5. Major Players of Tocilizumab
Table 6. Major Players of Aspirin
Table 7. Giant Cell Arteritis Therapeutic Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2021-2026)
Table 10. Giant Cell Arteritis Therapeutic Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Application (2021-2026)
Table 13. Global Giant Cell Arteritis Therapeutic Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Player (2021-2026)
Table 15. Giant Cell Arteritis Therapeutic Key Players Head office and Products Offered
Table 16. Giant Cell Arteritis Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Giant Cell Arteritis Therapeutic Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Region (2021-2026)
Table 21. Global Giant Cell Arteritis Therapeutic Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Giant Cell Arteritis Therapeutic Market Size Market Share by Country (2021-2026)
Table 25. Americas Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2021-2026)
Table 27. Americas Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Giant Cell Arteritis Therapeutic Market Size Market Share by Application (2021-2026)
Table 29. APAC Giant Cell Arteritis Therapeutic Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Giant Cell Arteritis Therapeutic Market Size Market Share by Region (2021-2026)
Table 31. APAC Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Giant Cell Arteritis Therapeutic Market Size Market Share by Country (2021-2026)
Table 35. Europe Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Giant Cell Arteritis Therapeutic
Table 41. Key Market Challenges & Risks of Giant Cell Arteritis Therapeutic
Table 42. Key Industry Trends of Giant Cell Arteritis Therapeutic
Table 43. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Giant Cell Arteritis Therapeutic Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Sanofi Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 48. Sanofi Giant Cell Arteritis Therapeutic Product Offered
Table 49. Sanofi Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Sanofi Main Business
Table 51. Sanofi Latest Developments
Table 52. Kiniksa Pharmaceuticals, Ltd. Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 53. Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Product Offered
Table 54. Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Kiniksa Pharmaceuticals, Ltd. Main Business
Table 56. Kiniksa Pharmaceuticals, Ltd. Latest Developments
Table 57. Regeneron Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 58. Regeneron Giant Cell Arteritis Therapeutic Product Offered
Table 59. Regeneron Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Regeneron Main Business
Table 61. Regeneron Latest Developments
Table 62. GlaxoSmithKline plc Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 63. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product Offered
Table 64. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. GlaxoSmithKline plc Main Business
Table 66. GlaxoSmithKline plc Latest Developments
Table 67. F. Hoffmann-La Roche Ltd. Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 68. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product Offered
Table 69. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. F. Hoffmann-La Roche Ltd. Main Business
Table 71. F. Hoffmann-La Roche Ltd. Latest Developments
Table 72. Novartis AG Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 73. Novartis AG Giant Cell Arteritis Therapeutic Product Offered
Table 74. Novartis AG Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Novartis AG Main Business
Table 76. Novartis AG Latest Developments
Table 77. AbbVie, Inc. Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 78. AbbVie, Inc. Giant Cell Arteritis Therapeutic Product Offered
Table 79. AbbVie, Inc. Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. AbbVie, Inc. Main Business
Table 81. AbbVie, Inc. Latest Developments
Table 82. Bristol-Myers Squibb Company Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 83. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product Offered
Table 84. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Bristol-Myers Squibb Company Main Business
Table 86. Bristol-Myers Squibb Company Latest Developments
Table 87. Abbott Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 88. Abbott Giant Cell Arteritis Therapeutic Product Offered
Table 89. Abbott Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Abbott Main Business
Table 91. Abbott Latest Developments
Table 92. Johnson & Johnson Services, Inc. Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 93. Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Product Offered
Table 94. Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Johnson & Johnson Services, Inc. Main Business
Table 96. Johnson & Johnson Services, Inc. Latest Developments
Table 97. Johns Hopkins Hospital Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 98. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product Offered
Table 99. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Johns Hopkins Hospital Main Business
Table 101. Johns Hopkins Hospital Latest Developments
Table 102. Fortis Healthcare Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 103. Fortis Healthcare Giant Cell Arteritis Therapeutic Product Offered
Table 104. Fortis Healthcare Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Fortis Healthcare Main Business
Table 106. Fortis Healthcare Latest Developments
Table 107. American College of Rheumatology Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 108. American College of Rheumatology Giant Cell Arteritis Therapeutic Product Offered
Table 109. American College of Rheumatology Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. American College of Rheumatology Main Business
Table 111. American College of Rheumatology Latest Developments
Table 112. Duke University Health System Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 113. Duke University Health System Giant Cell Arteritis Therapeutic Product Offered
Table 114. Duke University Health System Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Duke University Health System Main Business
Table 116. Duke University Health System Latest Developments
Table 117. Lahey Clinic Foundation Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 118. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product Offered
Table 119. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Lahey Clinic Foundation Main Business
Table 121. Lahey Clinic Foundation Latest Developments
Table 1. Giant Cell Arteritis Therapeutic Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Giant Cell Arteritis Therapeutic Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Prednisone
Table 4. Major Players of Methotrexate
Table 5. Major Players of Tocilizumab
Table 6. Major Players of Aspirin
Table 7. Giant Cell Arteritis Therapeutic Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2021-2026)
Table 10. Giant Cell Arteritis Therapeutic Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Application (2021-2026)
Table 13. Global Giant Cell Arteritis Therapeutic Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Player (2021-2026)
Table 15. Giant Cell Arteritis Therapeutic Key Players Head office and Products Offered
Table 16. Giant Cell Arteritis Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Giant Cell Arteritis Therapeutic Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Region (2021-2026)
Table 21. Global Giant Cell Arteritis Therapeutic Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Giant Cell Arteritis Therapeutic Market Size Market Share by Country (2021-2026)
Table 25. Americas Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2021-2026)
Table 27. Americas Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Giant Cell Arteritis Therapeutic Market Size Market Share by Application (2021-2026)
Table 29. APAC Giant Cell Arteritis Therapeutic Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Giant Cell Arteritis Therapeutic Market Size Market Share by Region (2021-2026)
Table 31. APAC Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Giant Cell Arteritis Therapeutic Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Giant Cell Arteritis Therapeutic Market Size Market Share by Country (2021-2026)
Table 35. Europe Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Giant Cell Arteritis Therapeutic
Table 41. Key Market Challenges & Risks of Giant Cell Arteritis Therapeutic
Table 42. Key Industry Trends of Giant Cell Arteritis Therapeutic
Table 43. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Giant Cell Arteritis Therapeutic Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Sanofi Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 48. Sanofi Giant Cell Arteritis Therapeutic Product Offered
Table 49. Sanofi Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Sanofi Main Business
Table 51. Sanofi Latest Developments
Table 52. Kiniksa Pharmaceuticals, Ltd. Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 53. Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Product Offered
Table 54. Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Kiniksa Pharmaceuticals, Ltd. Main Business
Table 56. Kiniksa Pharmaceuticals, Ltd. Latest Developments
Table 57. Regeneron Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 58. Regeneron Giant Cell Arteritis Therapeutic Product Offered
Table 59. Regeneron Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Regeneron Main Business
Table 61. Regeneron Latest Developments
Table 62. GlaxoSmithKline plc Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 63. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product Offered
Table 64. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. GlaxoSmithKline plc Main Business
Table 66. GlaxoSmithKline plc Latest Developments
Table 67. F. Hoffmann-La Roche Ltd. Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 68. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product Offered
Table 69. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. F. Hoffmann-La Roche Ltd. Main Business
Table 71. F. Hoffmann-La Roche Ltd. Latest Developments
Table 72. Novartis AG Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 73. Novartis AG Giant Cell Arteritis Therapeutic Product Offered
Table 74. Novartis AG Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Novartis AG Main Business
Table 76. Novartis AG Latest Developments
Table 77. AbbVie, Inc. Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 78. AbbVie, Inc. Giant Cell Arteritis Therapeutic Product Offered
Table 79. AbbVie, Inc. Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. AbbVie, Inc. Main Business
Table 81. AbbVie, Inc. Latest Developments
Table 82. Bristol-Myers Squibb Company Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 83. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product Offered
Table 84. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Bristol-Myers Squibb Company Main Business
Table 86. Bristol-Myers Squibb Company Latest Developments
Table 87. Abbott Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 88. Abbott Giant Cell Arteritis Therapeutic Product Offered
Table 89. Abbott Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Abbott Main Business
Table 91. Abbott Latest Developments
Table 92. Johnson & Johnson Services, Inc. Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 93. Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Product Offered
Table 94. Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Johnson & Johnson Services, Inc. Main Business
Table 96. Johnson & Johnson Services, Inc. Latest Developments
Table 97. Johns Hopkins Hospital Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 98. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product Offered
Table 99. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Johns Hopkins Hospital Main Business
Table 101. Johns Hopkins Hospital Latest Developments
Table 102. Fortis Healthcare Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 103. Fortis Healthcare Giant Cell Arteritis Therapeutic Product Offered
Table 104. Fortis Healthcare Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Fortis Healthcare Main Business
Table 106. Fortis Healthcare Latest Developments
Table 107. American College of Rheumatology Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 108. American College of Rheumatology Giant Cell Arteritis Therapeutic Product Offered
Table 109. American College of Rheumatology Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. American College of Rheumatology Main Business
Table 111. American College of Rheumatology Latest Developments
Table 112. Duke University Health System Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 113. Duke University Health System Giant Cell Arteritis Therapeutic Product Offered
Table 114. Duke University Health System Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Duke University Health System Main Business
Table 116. Duke University Health System Latest Developments
Table 117. Lahey Clinic Foundation Details, Company Type, Giant Cell Arteritis Therapeutic Area Served and Its Competitors
Table 118. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product Offered
Table 119. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Lahey Clinic Foundation Main Business
Table 121. Lahey Clinic Foundation Latest Developments
LIST OF FIGURES
Figure 1. Giant Cell Arteritis Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Giant Cell Arteritis Therapeutic Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Giant Cell Arteritis Therapeutic Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Giant Cell Arteritis Therapeutic Sales Market Share by Country/Region (2025)
Figure 8. Giant Cell Arteritis Therapeutic Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Type in 2025
Figure 10. Giant Cell Arteritis Therapeutic in Corticosteroids
Figure 11. Global Giant Cell Arteritis Therapeutic Market: Corticosteroids (2021-2026) & ($ millions)
Figure 12. Giant Cell Arteritis Therapeutic in Immunosuppressive Agents
Figure 13. Global Giant Cell Arteritis Therapeutic Market: Immunosuppressive Agents (2021-2026) & ($ millions)
Figure 14. Giant Cell Arteritis Therapeutic in Anticoagulants
Figure 15. Global Giant Cell Arteritis Therapeutic Market: Anticoagulants (2021-2026) & ($ millions)
Figure 16. Giant Cell Arteritis Therapeutic in Others
Figure 17. Global Giant Cell Arteritis Therapeutic Market: Others (2021-2026) & ($ millions)
Figure 18. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Application in 2025
Figure 19. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Player in 2025
Figure 20. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Region (2021-2026)
Figure 21. Americas Giant Cell Arteritis Therapeutic Market Size 2021-2026 ($ millions)
Figure 22. APAC Giant Cell Arteritis Therapeutic Market Size 2021-2026 ($ millions)
Figure 23. Europe Giant Cell Arteritis Therapeutic Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size 2021-2026 ($ millions)
Figure 25. Americas Giant Cell Arteritis Therapeutic Value Market Share by Country in 2025
Figure 26. United States Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Giant Cell Arteritis Therapeutic Market Size Market Share by Region in 2025
Figure 31. APAC Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2021-2026)
Figure 32. APAC Giant Cell Arteritis Therapeutic Market Size Market Share by Application (2021-2026)
Figure 33. China Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 37. India Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Giant Cell Arteritis Therapeutic Market Size Market Share by Country in 2025
Figure 40. Europe Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2021-2026)
Figure 41. Europe Giant Cell Arteritis Therapeutic Market Size Market Share by Application (2021-2026)
Figure 42. Germany Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 43. France Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 56. APAC Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 57. Europe Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 59. United States Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 60. Canada Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 61. Mexico Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 62. Brazil Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 63. China Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 64. Japan Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 65. Korea Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 67. India Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 68. Australia Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 69. Germany Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 70. France Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 71. UK Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 72. Italy Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 73. Russia Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 74. Egypt Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 75. South Africa Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 76. Israel Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 77. Turkey Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 78. Global Giant Cell Arteritis Therapeutic Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Giant Cell Arteritis Therapeutic Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 1. Giant Cell Arteritis Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Giant Cell Arteritis Therapeutic Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Giant Cell Arteritis Therapeutic Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Giant Cell Arteritis Therapeutic Sales Market Share by Country/Region (2025)
Figure 8. Giant Cell Arteritis Therapeutic Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Type in 2025
Figure 10. Giant Cell Arteritis Therapeutic in Corticosteroids
Figure 11. Global Giant Cell Arteritis Therapeutic Market: Corticosteroids (2021-2026) & ($ millions)
Figure 12. Giant Cell Arteritis Therapeutic in Immunosuppressive Agents
Figure 13. Global Giant Cell Arteritis Therapeutic Market: Immunosuppressive Agents (2021-2026) & ($ millions)
Figure 14. Giant Cell Arteritis Therapeutic in Anticoagulants
Figure 15. Global Giant Cell Arteritis Therapeutic Market: Anticoagulants (2021-2026) & ($ millions)
Figure 16. Giant Cell Arteritis Therapeutic in Others
Figure 17. Global Giant Cell Arteritis Therapeutic Market: Others (2021-2026) & ($ millions)
Figure 18. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Application in 2025
Figure 19. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Player in 2025
Figure 20. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Region (2021-2026)
Figure 21. Americas Giant Cell Arteritis Therapeutic Market Size 2021-2026 ($ millions)
Figure 22. APAC Giant Cell Arteritis Therapeutic Market Size 2021-2026 ($ millions)
Figure 23. Europe Giant Cell Arteritis Therapeutic Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size 2021-2026 ($ millions)
Figure 25. Americas Giant Cell Arteritis Therapeutic Value Market Share by Country in 2025
Figure 26. United States Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Giant Cell Arteritis Therapeutic Market Size Market Share by Region in 2025
Figure 31. APAC Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2021-2026)
Figure 32. APAC Giant Cell Arteritis Therapeutic Market Size Market Share by Application (2021-2026)
Figure 33. China Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 37. India Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Giant Cell Arteritis Therapeutic Market Size Market Share by Country in 2025
Figure 40. Europe Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2021-2026)
Figure 41. Europe Giant Cell Arteritis Therapeutic Market Size Market Share by Application (2021-2026)
Figure 42. Germany Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 43. France Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Giant Cell Arteritis Therapeutic Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 56. APAC Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 57. Europe Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 59. United States Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 60. Canada Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 61. Mexico Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 62. Brazil Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 63. China Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 64. Japan Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 65. Korea Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 67. India Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 68. Australia Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 69. Germany Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 70. France Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 71. UK Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 72. Italy Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 73. Russia Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 74. Egypt Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 75. South Africa Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 76. Israel Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 77. Turkey Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
Figure 78. Global Giant Cell Arteritis Therapeutic Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Giant Cell Arteritis Therapeutic Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Giant Cell Arteritis Therapeutic Market Size 2027-2032 ($ millions)
